Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020
- PMID: 32360481
- PMCID: PMC7191275
- DOI: 10.1016/j.phrs.2020.104821
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020
Abstract
Aim: Since December 2019, new COVID-19 outbreaks have occurred and spread around the world. However, the clinical characteristics of patients in other areas around Wuhan, Hubei Province are still unclear. In this study, we performed epidemiological and clinical characteristics analysis on these regional cases.
Methods: We retrospectively investigated COVID-19 patients positively confirmed by nucleic acid Q-PCR at Taihe Hospital from January 16 to February 4, 2020. Their epidemiological, clinical manifestations, and imaging characteristics were analysed.
Results: Among the 73 patients studied, 12.3 % developed symptoms after returning to Shiyan from Wuhan, and 71.2 % had a history of close contact with Wuhan personnel or confirmed cases. Among these patients, 9 cases were associated with family clustering. The first main symptoms presented by these patients were fever (84.9 %) and cough (21.9 %). The longest incubation period was 26 days, and the median interval from the first symptoms to admission was 5 days. Of the patients, 67.1 % were originally healthy people with no underlying diseases, others mostly had common comorbidities including hypertension (12.3 %) and diabetes (5.5 %), 10.9 % were current smokers, 30.1 % had low white blood cell counts and 45.2 % showed decreased lymphocytes at the first time of diagnosis. CT scans showed that multiple patchy ground glass shadows outside of the patient lungs were commonly observed, and a single sub-pleural sheet of ground glass shadow with enhanced vascular bundles was also found located under the pleura. Patient follow-up to February 14 presented 38.4 % severe cases and 2.7 % critical cases. After follow-up, the parameter of lymphocyte counts below 0.8 × 109/L cannot be used to predict severe and critical groups from the ordinary group, and a lower proportion of smokers and higher proportion of diabetes patients occur in the poor outcome group. Other co-morbidities are observed but did not lead to poor outcomes.
Conclusion: The epidemiological characteristics of patients in the area around Wuhan, such as Shiyan, at first diagnosis are described as follows: Patients had histories of Wuhan residences in the early stage and family clustering in the later period. The incubation period was relatively long, and the incidence was relatively hidden, but the virulence was relatively low. The initial diagnosis of the patients was mostly ordinary, and the percentage of critical patients who evolved into the ICU during follow-up is 2.7 %, which is lower than the 26.1 % reported by Wuhan city. According to the Shiyan experience, early diagnosis with multiple swaps of the Q-PCR test and timely treatment can reduce the death rate. Diabetes could be one of the risk factors for progression to severe/critical outcomes. No evidence exists that smoking protects COVID-19 patients from developing to severe/critical cases, and the absolute number of lymphocytes at initial diagnosis could not predict the progression risk from severe to critical condition. Multivariate regression analysis should be used to further guide the allocation of clinical resources.
Keywords: COVID-19; Clinical characteristics; Epidemiology; Novel coronavirus pneumonia.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no competing interests.
Figures
Similar articles
-
Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.J Med Microbiol. 2020 Aug;69(8):1114-1123. doi: 10.1099/jmm.0.001231. J Med Microbiol. 2020. PMID: 32783802 Free PMC article.
-
Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a single-center descriptive study.BMC Infect Dis. 2020 Jul 29;20(1):549. doi: 10.1186/s12879-020-05252-8. BMC Infect Dis. 2020. PMID: 32727456 Free PMC article.
-
Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.Arch Gynecol Obstet. 2020 Sep;302(3):545-551. doi: 10.1007/s00404-020-05573-8. Epub 2020 Jul 21. Arch Gynecol Obstet. 2020. PMID: 32696241 Free PMC article. Review.
-
The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.J Clin Virol. 2020 Jul;128:104397. doi: 10.1016/j.jcv.2020.104397. Epub 2020 Apr 30. J Clin Virol. 2020. PMID: 32388472 Free PMC article.
-
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x. Infect Dis Poverty. 2020. PMID: 32183901 Free PMC article. Review.
Cited by
-
Nomogram-based prediction model for survival of COVID-19 patients: A clinical study.Heliyon. 2023 Sep 14;9(9):e20137. doi: 10.1016/j.heliyon.2023.e20137. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809383 Free PMC article.
-
The impact of systemic hypertension on outcomes in hospitalized COVID-19 patients - a systematic review.Afr Health Sci. 2022 Dec;22(4):505-518. doi: 10.4314/ahs.v22i4.57. Afr Health Sci. 2022. PMID: 37092039 Free PMC article.
-
Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms.Brain Hemorrhages. 2023 Sep;4(3):154-173. doi: 10.1016/j.hest.2023.02.001. Brain Hemorrhages. 2023. PMID: 36789140 Free PMC article. Review.
-
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors.Front Immunol. 2022 Jun 10;13:912336. doi: 10.3389/fimmu.2022.912336. eCollection 2022. Front Immunol. 2022. PMID: 35757770 Free PMC article. Review.
-
Does COVID-19 threat increase xenophobia? The roles of protection efficacy and support seeking.BMC Public Health. 2022 Mar 11;22(1):485. doi: 10.1186/s12889-022-12912-8. BMC Public Health. 2022. PMID: 35277156 Free PMC article.
References
-
- C.-N.I.R.S. Team COVID-19, Australia: epidemiology report 2 (Reporting week ending 19:00 AEDT 8 February 2020) Commun. Dis. Intell. 2018;44(2020) - PubMed
-
- Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z.W., Tian J.H., Pei Y.Y., Yuan M.L., Zhang Y.L., Dai F.H., Liu Y., Wang Q.M., Zheng J.J., Xu L., Holmes E.C., Zhang Y.Z. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265–269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3. - DOI - PMC - PubMed
-
- NHC-China, SATCM-China The guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia. Chin. J. Integr. Tradit. Western Med. 2020:1–3.
-
- Song H.-D., Tu C.-C., Zhang G.-W., Wang S.-Y., Zheng K., Lei L.-C., Chen Q.-X., Gao Y.-W., Zhou H.-Q., Xiang H., Zheng H.-J., Chern S.-W.W., Cheng F., Pan C.-M., Xuan H., Chen S.-J., Luo H.-M., Zhou D.-H., Liu Y.-F., He J.-F., Qin P.-Z., Li L.-H., Ren Y.-Q., Liang W.-J., Yu Y.-D., Anderson L., Wang M., Xu R.-H., Wu X.-W., Zheng H.-Y., Chen J.-D., Liang G., Gao Y., Liao M., Fang L., Jiang L.-Y., Li H., Chen F., Di B., He L.-J., Lin J.-Y., Tong S., Kong X., Du L., Hao P., Tang H., Bernini A., Yu X.-J., Spiga O., Zong-Ming Guon H.-Y.P., He W.-Z., Manuguerra J.-C., Fontanet A., Danchin A., Niccolai N., Li Y.-X., Wu C.-I., Zhao G.-P. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl. Acad. Sci. U. S. A. 2005;102(7):2430–2435. - PMC - PubMed
-
- Meduri G.U., Bridges L., Shih M.C., Marik P.E., Siemieniuk R.A.C., Kocak M. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016;42(5):829–840. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical